title: Comment: the impact of methodological approach on cost findings in comparison of epoetin alfa with darbepoetin alfa.
authors.forename: Patrick
authors.initials: P
authors.lastname: Lefebvre
authors.forename: Francis
authors.initials: F
authors.lastname: Vekeman
authors.forename: Pierre-Yves
authors.initials: PY
authors.lastname: Cremieux
mesh_terms: D000068256:Darbepoetin alfa; D004305:Dose-Response Relationship, Drug; D016527:Drug Costs; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000191:economics*; D006397:Hematinics / Q000008:administration & dosage / Q000191:economics*; D006801:Humans; D011994:Recombinant Proteins; D012107:Research Design; D013997:Time Factors
chemical_list: D006397:Hematinics; D011994:Recombinant Proteins; D004921:Erythropoietin; D000068256:Darbepoetin alfa; D000068817:Epoetin Alfa